[Retracted] Assessing the Prognostic Performance of the Child-Pugh, Model for End-Stage Liver Disease, and Albumin-Bilirubin Scores in Patients with Decompensated Cirrhosis: A Large Asian Cohort from Gastroenterology Department
Table 2
Comparison between the survival group and the nonsurvival group at the 28-day, 90-day, and 6-month follow-ups.
Parameter
28 days
90 days
6 months
Survivors
Nonsurvivors
value
Survivors
Nonsurvivors
value
Survivors
Nonsurvivors
value
ALT (IU/l)
26 (18-42)
25.5 (15.75-56)
0.512
25 (17-38.25)
27 (16-54.75)
0.114
23 (17-36)
26 (15-56)
0.040
AST (IU/l)
40 (28-68)
67.5 (38.25-168.25)
<0.001
38 (26-57)
64.5 (36.5-160.25)
<0.001
35.5 (26-53)
58 (36-168)
<0.001
Albumin (g/l)
28.8 (25.4-31.4)
25.05 (21.75-28.575)
<0.001
29 (25.8-32)
25.65 (22.8-29.275)
<0.001
29.1 (25.925-32.1)
25.7 (22.8-29.5)
<0.001
Bilirubin (mmol/l)
23.8 (15.5-39.9)
36.2 (21.125-73.425)
0.028
22.85 (14.85-38.7)
27.1 (17.75-58.25)
0.022
21.9 (14.3-37.475)
29.5 (19.6-57.2)
0.004
ALP (IU/l)
70 (53-101)
115 (68.25-175.5)
<0.001
68 (53-96)
98.5 (67.75-167)
<0.001
67 (51.25-92.75)
95 (67-168)
<0.001
GGT (IU/l)
23 (14-56)
38.5 (18-128.75)
0.020
21.5 (13.75-47.25)
38 (21-106.75)
<0.001
21 (13-48)
37 (17-106)
0.003
Creatinine (mmol/l)
72.4 (59.6-91.3)
92.55 (72.65-134.35)
<0.001
72.3 (59.525-88.875)
92.55 (64.05-135.88)
<0.001
71.45 (57.7-86.075)
91.9 (63.4-132.6)
<0.001
INR
1.31 (1.2-1.5)
1.48 (1.24-1.95)
<0.001
1.3 (1.18-1.483)
1.425 (1.27-1.75)
<0.001
1.31 (1.19-1.487)
1.4 (1.24-1.76)
<0.001
PT
14.7 (13.5-16.7)
15.1 (13.7-21.45)
0.002
14.65 (13.175-16.425)
15.6 (13.825-19.9)
<0.001
14.7 (13.025-16.4)
15.4 (13.7-19.9)
<0.001
Platelet (/l)
62 (41-96)
74 (28.25-115.5)
0.893
62 (40.75-92.25)
69 (32.25-108)
0.637
64 (41-92.75)
70 (37-109)
0.419
WBC (/l)
6.34 (3.95-9.48)
9.37 (4.648-14.973)
<0.001
6.33 (3.865-9.05)
8.15 (4.715-13.63)
0.001
6.295 (3.805-9.432)
7.75 (4.42-13.57)
0.003
Na (mmol/l)
138.4 (136-141)
140.15 (134.45-143.88)
0.168
138.95 (136-141)
138.45 (134.85-142.75)
0.939
138.6 (136-141.15)
138.5 (135-142)
0.967
Child-Pugh score
8 (7-10)
10 (8-11)
<0.001
8 (7-9)
9 (8-10.5)
<0.001
8 (7-9)
9.5 (8-11)
<0.001
MELD score
11 (9-14)
15 (11-23)
<0.001
10.5 (9-14)
15 (11-20)
<0.001
10 (9-14)
14 (11-19.5)
<0.001
MELD-Na score
12 (9-15.410)
16 (12.295-25)
<0.001
11 (9-15)
15 (11.59-23)
<0.001
11 (9-14)
15 (11.59-22.837)
<0.001
iMELD score
30.695 (27.1-35.578)
37.14 (30.335-42.35)
<0.001
30.3 (26.53-34.1)
35.9 (29.72-42.2)
<0.001
30.17 (26.568-34.265)
36.1 (29.72-41.9)
<0.001
ALBI score
-1.541 (-1.813~-1.140)
-1.031 (-1.507~-0.449)
<0.001
-1.548 (-1.851~-1.177)
-1.140 (-1.544~-0.635)
<0.001
-1.553 (-1.886~-1.228)
-1.152 (-1.562~-0.652)
<0.001
Data are expressed as the median (interquartile range). ALT: alanine aminotransferase; AST: aspartate aminotransferase; GGT: gamma-glutamyl transpeptidase; INR: international normalized ratio; PT: prothrombin time; WBC: white blood cell count; MELD: model for end-stage liver disease; MELD-Na: MELD combined with serum sodium concentration; iMELD: integrated MELD; ALBI: albumin-bilirubin score.
